1. Targeting oncogenic transcription factors by polyphenols: A novel approach for cancer therapy
   Chitra Rajagopal et al, 2018, Pharmacological Research CrossRef
2. Casticin impairs cell growth and induces cell apoptosis via cell cycle arrest in human oral cancer SCC-4 cells
   Guan-Ling Chou et al, 2017, Environmental Toxicology CrossRef
3. Casticin from Vitex species: a short review on its anticancer and anti-inflammatory properties
   Eric Wei Chiang Chan et al, 2018, Journal of Integrative Medicine CrossRef
4. Apoptotic effect of lambertianic acid through AMPK/FOXM1 signaling in MDA-MB231 breast cancer cells
   Jae Hee Lee et al, 2018, Phytotherapy Research CrossRef
5. Inhibition of Wnt3a/FOXM1/β-Catenin Axis and Activation of GSK3β and Caspases are Critically Involved in Apoptotic Effect of Moracin D in Breast Cancers
   Sung Hwang et al, 2018, IJMS CrossRef
6. Vitex negundo and its medicinal value
   Balraj Singh Gill et al, 2018, Mol Biol Rep CrossRef
7. Casticin inhibits breast cancer cell migration and invasion by down-regulation of PI3K/Akt signaling pathway
   Li Fan et al, 2018, Biosci. Rep. CrossRef
8. Hardaliyenin HT-29, DU-145, HeLa Kanser Hücreleri ve CF-1 (Fare Embriyonik Fibroblast) Hücresi FoxM1 Gen Expresyon Seviyelerine Etkisi
   Özge Kahraman Ilıkkan, 2017 CrossRef
9. The tumor suppressor FOXO3a mediates the response to EGFR inhibition in glioblastoma cells
   Guillem Ramis et al, 2019, Cell Oncol. CrossRef
10. BRCA1-IRIS inactivation sensitizes ovarian tumors to cisplatin
    B T Paul et al, 2015, Oncogene CrossRef
11. Casticin inhibits human prostate cancer DU 145 cell migration and invasion via Ras/Akt/NF-κB signaling pathways.
    Chia-Chang Lin et al, 2019, J Food Biochem CrossRef
12. Restoring TRAIL Mediated Signaling in Ovarian Cancer Cells
    Ammad Ahmad Farooqi et al, 2014, Arch. Immunol. Ther. Exp. CrossRef
13. Methylseleninic acid promotes antitumour effects via nuclear FOXO3a translocation through Akt inhibition
    Míriam Tarrado-Castellarnau et al, 2015, Pharmacological Research CrossRef
14. High MicroRNA-370 Expression Correlates with Tumor Progression and Poor Prognosis in Breast Cancer
    Jongmin Sim et al, 2015, J Breast Cancer CrossRef
15. Casticin induces DNA damage and inhibits DNA repair-associated protein expression in B16F10 mouse melanoma cancer cells
    Yung-Luen Shih et al, 2016 CrossRef
16. Casticin induced apoptotic cell death and altered associated gene expression in human colon cancer colo 205 cells
    Hung-Sheng Shang et al, 2017, Environmental Toxicology CrossRef
17. Inactivation of AKT, ERK and NF-κB by genistein derivative, 7-difluoromethoxyl-5,4′-di-n-octylygenistein, reduces ovarian carcinoma oncogenicity
    Yingxia Ning et al, 2017 CrossRef
18. Oncogenic regulation of tumor metabolic reprogramming
    Míriam Tarrado-Castellarnau et al, 2016, Oncotarget CrossRef
19. FOXO3a‑SIRT6 axis suppresses aerobic glycolysis in melanoma
    Zhen Dong et al, 2020, Int J Oncol CrossRef
20. Casticin inhibits the epithelial-mesenchymal transition in ovarian carcinoma via the hedgehog signaling pathway
    Jing Zhang et al, 2018, Oncol Lett CrossRef
21. The role of Anaphase Promoting Complex activation, inhibition and substrates in cancer development and progression.
    Cordell VanGenderen et al, 2020, Aging (Albany NY) CrossRef
22. Identification of dysregulated miRNAs ‐genes network in ovarian cancer: An integrative approach to uncover the molecular interactions and oncomechanisms
    Sepideh Kadkhoda et al, 2020, Cancer Reports CrossRef
23. T-Type Ca2+ Channel Inhibition Sensitizes Ovarian Cancer to Carboplatin
    Barbara Dziegielewska et al, 2016, Mol Cancer Ther CrossRef
24. FOXM1 and Cancer: Faulty Cellular Signaling Derails Homeostasis
    Dhanya Kalathil et al, 2021, Front. Oncol. CrossRef
25. Natural Products as Anticancer Agents: Current Status and Future Perspectives.
    Abid Naeem et al, 2022, Molecules CrossRef
26. Molecular effects of Mastodynon: realities and prospects for cancer prevention
    I. V. Vysotskaya et al, 2022, Opuholi ženskoj reproduktivnoj sistemy CrossRef
27. Heat Shock Proteins and Cancer: The FoxM1 Connection
    Zahra Alimardan et al, 2023, Biochemical Pharmacology CrossRef
28. FOXM1: A small fox that makes more tracks for cancer progression and metastasis
    Md Arafat Khan et al, 2023, Seminars in Cancer Biology CrossRef
29. Dispensary group of women with benign diseases of the mammary glands: a school of prevention, observation, examination, treatment
    E. A. Sukhareva et al, 2023, Medicinskij sovet CrossRef
30. Casticin as potential anticancer agent: recent advancements in multi-mechanistic approaches
    Katya Carbone et al, 2023, Front. Mol. Biosci. CrossRef
31. Small-molecule inhibitors targeting FOXM1: Current challenges and future perspectives in cancer treatments
    Sanjeev Raghuwanshi et al, 2023, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
32. FOXO3a-interacting proteins’ involvement in cancer: a review
    Zhiqiang Dong et al, 2024, Mol Biol Rep CrossRef
33. Cancer Drug Resistance and Metabolic Reprogramming
    Shariqa Jan et al, 2024 CrossRef
34. Casticin-Induced Inhibition of Cell Growth and Survival Are Mediated through the Dual Modulation of Akt/mTOR Signaling Cascade.
    Jong Hyun Lee et al, 2019, Cancers (Basel) CrossRef
35. An Overview of the Potential Antineoplastic Effects of Casticin
    Shanaya Ramchandani et al, 2020, Molecules CrossRef